Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Van Den Berg Management I Inc.

Van Den Berg Management I Inc. boosted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 133.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,588 shares of the medical research company's stock after acquiring an additional 4,907 shares during the period. Van Den Berg Management I Inc.'s holdings in Thermo Fisher Scientific were worth $4,468,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Empire Financial Management Company LLC lifted its holdings in shares of Thermo Fisher Scientific by 8.5% during the fourth quarter. Empire Financial Management Company LLC now owns 2,130 shares of the medical research company's stock worth $1,108,000 after purchasing an additional 166 shares during the period. Dauntless Investment Group LLC acquired a new stake in shares of Thermo Fisher Scientific in the 4th quarter worth $240,000. Integrated Wealth Concepts LLC boosted its holdings in shares of Thermo Fisher Scientific by 11.5% in the fourth quarter. Integrated Wealth Concepts LLC now owns 6,329 shares of the medical research company's stock valued at $3,292,000 after acquiring an additional 652 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. increased its stake in shares of Thermo Fisher Scientific by 7.0% during the fourth quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 22,856 shares of the medical research company's stock worth $11,945,000 after acquiring an additional 1,500 shares during the period. Finally, Burling Wealth Partners LLC acquired a new stake in Thermo Fisher Scientific in the fourth quarter valued at about $508,000. 89.23% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Scotiabank reduced their price target on Thermo Fisher Scientific from $650.00 to $605.00 and set a "sector perform" rating for the company in a report on Friday. Robert W. Baird decreased their target price on shares of Thermo Fisher Scientific from $603.00 to $573.00 and set an "outperform" rating on the stock in a research report on Thursday. Sanford C. Bernstein upgraded shares of Thermo Fisher Scientific from a "market perform" rating to an "outperform" rating and set a $630.00 price target for the company in a report on Friday, January 10th. UBS Group lowered their target price on shares of Thermo Fisher Scientific from $715.00 to $500.00 and set a "buy" rating on the stock in a research report on Thursday. Finally, Citigroup reduced their price target on shares of Thermo Fisher Scientific from $650.00 to $570.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $616.95.

Insider Activity

In other news, SVP Michael A. Boxer sold 3,775 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $532.52, for a total transaction of $2,010,263.00. Following the completion of the transaction, the senior vice president now directly owns 10,816 shares of the company's stock, valued at approximately $5,759,736.32. This represents a 25.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gianluca Pettiti sold 300 shares of the firm's stock in a transaction that occurred on Tuesday, February 4th. The stock was sold at an average price of $585.59, for a total value of $175,677.00. Following the completion of the sale, the executive vice president now directly owns 16,363 shares in the company, valued at approximately $9,582,009.17. This trade represents a 1.80 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 23,900 shares of company stock valued at $13,106,062. Company insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Stock Down 0.6 %

Shares of NYSE:TMO traded down $2.69 during mid-day trading on Monday, hitting $421.55. 2,527,205 shares of the company traded hands, compared to its average volume of 1,746,667. The firm has a market cap of $159.13 billion, a P/E ratio of 25.50, a PEG ratio of 2.99 and a beta of 0.86. Thermo Fisher Scientific Inc. has a 52-week low of $409.85 and a 52-week high of $627.88. The firm's 50 day simple moving average is $487.28 and its 200 day simple moving average is $526.70. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.29 and a current ratio of 1.66.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The medical research company reported $5.15 EPS for the quarter, topping the consensus estimate of $5.10 by $0.05. Thermo Fisher Scientific had a return on equity of 17.51% and a net margin of 14.78%. The business had revenue of $10.36 billion for the quarter, compared to analysts' expectations of $10.23 billion. During the same quarter in the previous year, the firm posted $5.11 earnings per share. The company's revenue was up .2% compared to the same quarter last year. On average, equities analysts anticipate that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Friday, March 14th were issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 0.41%. This is a boost from Thermo Fisher Scientific's previous quarterly dividend of $0.39. The ex-dividend date was Friday, March 14th. Thermo Fisher Scientific's dividend payout ratio is 10.09%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.